[{"address1": "270 Longwood Road South", "city": "Hamilton", "state": "ON", "zip": "L8P 0A6", "country": "Canada", "phone": "289 799 0891", "website": "https://www.fusionpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canada and the United States. The company's lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and FPI-1434 that is in Phase 1 clinical trial as a monotherapy in patients with solid tumors expressing that target insulin-like growth factor 1 receptor. It is conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, the company develops FPI-1966 for the treatment of multiple cancers, including colorectal, ovarian, bladder, and head and neck cancers.; FPI-2068, a bispecific antibody, which is in Phase 1 clinical trial targeting epidermal growth factor receptor, and mesenchymal epithelial transition factor. It has a strategic collaboration agreement with AstraZeneca UK Limited to discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. The company was incorporated in 2014 and is headquartered in Hamilton, Canada.", "fullTimeEmployees": 101, "companyOfficers": [{"maxAge": 1, "name": "Dr. John F. Valliant Ph.D.", "age": 52, "title": "Founder, CEO & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 911336, "exercisedValue": 0, "unexercisedValue": 13458175}, {"maxAge": 1, "name": "Mr. Mohit  Rawat", "age": 43, "title": "President & Chief Business Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 706078, "exercisedValue": 0, "unexercisedValue": 666228}, {"maxAge": 1, "name": "Mr. John J. Crowley CPA", "age": 49, "title": "CFO & Compliance Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 719818, "exercisedValue": 0, "unexercisedValue": 3057000}, {"maxAge": 1, "name": "Dr. Eric  Burak Ph.D.", "age": 58, "title": "Chief Technology Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 638040, "exercisedValue": 0, "unexercisedValue": 570916}, {"maxAge": 1, "name": "Dr. Christopher Paul Leamon Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amanda  Cray", "title": "Senior Director of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria D. Stahl", "age": 52, "title": "Chief Legal Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric S. Hoffman Ph.D.", "age": 53, "title": "Senior Vice President of Business Development", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cara  Ferreira Ph.D.", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joanne  Schindler", "title": "Executive Vice President of Medical Director & Clinical Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 21.5, "open": 21.5, "dayLow": 21.46, "dayHigh": 21.53, "regularMarketPreviousClose": 21.5, "regularMarketOpen": 21.5, "regularMarketDayLow": 21.46, "regularMarketDayHigh": 21.53, "beta": -0.689, "forwardPE": -12.785714, "volume": 420577, "regularMarketVolume": 420577, "averageVolume": 1853473, "averageVolume10days": 324150, "averageDailyVolume10Day": 324150, "bid": 15.43, "ask": 27.58, "bidSize": 200, "askSize": 200, "marketCap": 1827088768, "fiftyTwoWeekLow": 2.31, "fiftyTwoWeekHigh": 21.58, "priceToSalesTrailing12Months": 895.6318, "fiftyDayAverage": 20.9258, "twoHundredDayAverage": 9.9597, "currency": "USD", "enterpriseValue": 1681110016, "floatShares": 61576610, "sharesOutstanding": 85060000, "sharesShort": 3947961, "sharesShortPriorMonth": 5198824, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.0464, "heldPercentInsiders": 0.00468, "heldPercentInstitutions": 0.86754, "shortRatio": 3.65, "shortPercentOfFloat": 0.0545, "impliedSharesOutstanding": 85139200, "bookValue": 2.85, "priceToBook": 7.5368423, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -104276000, "trailingEps": -1.4, "forwardEps": -1.68, "enterpriseToRevenue": 824.074, "enterpriseToEbitda": -15.451, "52WeekChange": 3.9722223, "SandP52WeekChange": 0.26137078, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "FUSN", "underlyingSymbol": "FUSN", "shortName": "Fusion Pharmaceuticals Inc.", "longName": "Fusion Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1593178200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d9536ffd-ba4c-326e-b439-759f4bfcfe15", "messageBoardId": "finmb_421477092", "gmtOffSetMilliseconds": -14400000, "currentPrice": 21.48, "targetHighPrice": 23.0, "targetLowPrice": 20.0, "targetMeanPrice": 21.13, "targetMedianPrice": 21.0, "recommendationMean": 2.8, "recommendationKey": "hold", "numberOfAnalystOpinions": 8, "totalCash": 210524992, "totalCashPerShare": 2.475, "ebitda": -108804000, "totalDebt": 64547000, "quickRatio": 10.368, "currentRatio": 10.644, "totalRevenue": 2040000, "debtToEquity": 26.691, "revenuePerShare": 0.028, "returnOnAssets": -0.23341, "returnOnEquity": -0.47112998, "freeCashflow": -57107000, "operatingCashflow": -83673000, "operatingMargins": -54.03775, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-26"}]